These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 39062979)

  • 1. Autotaxin-Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications.
    Laface C; Ricci AD; Vallarelli S; Ostuni C; Rizzo A; Ambrogio F; Centonze M; Schirizzi A; De Leonardis G; D'Alessandro R; Lotesoriere C; Giannelli G
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.
    Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC
    Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis.
    Magkrioti C; Oikonomou N; Kaffe E; Mouratis MA; Xylourgidis N; Barbayianni I; Megadoukas P; Harokopos V; Valavanis C; Chun J; Kosma A; Stathopoulos GT; Bouros E; Bouros D; Syrigos K; Aidinis V
    Cancer Res; 2018 Jul; 78(13):3634-3644. PubMed ID: 29724718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Expression Regulation and Biological Function of Autotaxin.
    Zhang X; Li M; Yin N; Zhang J
    Cells; 2021 Apr; 10(4):. PubMed ID: 33921676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autotaxin and LPA receptor signaling in cancer.
    Houben AJ; Moolenaar WH
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):557-65. PubMed ID: 22002750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A defective lysophosphatidic acid-autophagy axis increases miscarriage risk by restricting decidual macrophage residence.
    Yang HL; Lai ZZ; Shi JW; Zhou WJ; Mei J; Ye JF; Zhang T; Wang J; Zhao JY; Li DJ; Li MQ
    Autophagy; 2022 Oct; 18(10):2459-2480. PubMed ID: 35220880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis.
    Gotoh M; Fujiwara Y; Yue J; Liu J; Lee S; Fells J; Uchiyama A; Murakami-Murofushi K; Kennel S; Wall J; Patil R; Gupte R; Balazs L; Miller DD; Tigyi GJ
    Biochem Soc Trans; 2012 Feb; 40(1):31-6. PubMed ID: 22260662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function relationships of autotaxin, a secreted lysophospholipase D.
    Hausmann J; Perrakis A; Moolenaar WH
    Adv Biol Regul; 2013 Jan; 53(1):112-7. PubMed ID: 23069371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic acid produced by autotaxin acts as an allosteric modulator of its catalytic efficiency.
    Salgado-Polo F; Fish A; Matsoukas MT; Heidebrecht T; Keune WJ; Perrakis A
    J Biol Chem; 2018 Sep; 293(37):14312-14327. PubMed ID: 30026231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the autotaxin/LPA axis in cancer development and metastasis.
    Leblanc R; Peyruchaud O
    Exp Cell Res; 2015 May; 333(2):183-189. PubMed ID: 25460336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The critical role and potential target of the autotaxin/lysophosphatidate axis in pancreatic cancer.
    Quan M; Cui JJ; Feng X; Huang Q
    Tumour Biol; 2017 Mar; 39(3):1010428317694544. PubMed ID: 28347252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders.
    Alioli C; Demesmay L; Peyruchaud O; Machuca-Gayet I
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role and therapeutic potential of the autotaxin-lysophosphatidate signalling axis in breast cancer.
    Teo K; Brunton VG
    Biochem J; 2014 Oct; 463(1):157-65. PubMed ID: 25195735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis.
    Orosa B; García S; Conde C
    Eur J Pharmacol; 2015 Oct; 765():228-33. PubMed ID: 26297977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autotaxin, Pruritus and Primary Biliary Cholangitis (PBC).
    Sun Y; Zhang W; Evans JF; Floreani A; Zou Z; Nishio Y; Qi R; Leung PS; Bowlus CL; Gershwin ME
    Autoimmun Rev; 2016 Aug; 15(8):795-800. PubMed ID: 27019050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of Osteopontin in the migration and protection against Taxol-induced apoptosis via the ATX-LPA axis in SGC7901 cells.
    Zhang R; Wang J; Ma S; Huang Z; Zhang G
    BMC Cell Biol; 2011 Mar; 12():11. PubMed ID: 21406114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways.
    Ryu JM; Han HJ
    Stem Cells; 2015 Mar; 33(3):819-32. PubMed ID: 25376707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the autotaxin-lysophosphatidate axis in the development of resistance to cancer therapy.
    Tang X; Benesch MGK; Brindley DN
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158716. PubMed ID: 32305571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
    Okudaira S; Yukiura H; Aoki J
    Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis.
    Black KE; Berdyshev E; Bain G; Castelino FV; Shea BS; Probst CK; Fontaine BA; Bronova I; Goulet L; Lagares D; Ahluwalia N; Knipe RS; Natarajan V; Tager AM
    FASEB J; 2016 Jun; 30(6):2435-50. PubMed ID: 27006447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.